BACKGROUND: The pan-influenza A real-time RT-PCR detection assay developed by the Centers for Disease Control and Prevention (CDC) during the 2009 pandemic is widely utilized. A quantitative version of the assay may be useful to monitor influenza A infection and response to treatment. OBJECTIVES: To prove in principle the possibility that a virtual quantification tool (VQT) would allow conversion of CDC real-time RT-PCR cycle threshold (Ct) values in virus RNA copy number. STUDY DESIGN: A plasmid carrying the CDC real-time RT-PCR target region of the influenza A Matrix (M) gene was generated. In a multicenter study, a set of 5 ten-fold dilutions (equivalent to 1×10(2) to 1×10(6)copies/reaction) were prepared and distributed to the 4 participating virology laboratories and then amplified to generate a virtual quantification standard curve. Clinical samples (n=120) were quantified in parallel by interpolation with locally generated standard curves and using the VQT. RESULTS: A total of 40 standard curves were obtained by the participating centers (ten from each center). The intra- and inter-laboratory variability showed a coefficient of variation (CV) ≤5%. Influenza A virus quantification in 120 respiratory samples showed a significant correlation between interpolation with locally generated standard curves and the VQT (R(2)=0.9655). Bland Altman analysis showed that the majority (no. 111, 92.5%) of clinical samples had <0.5 log(10) variation. CONCLUSIONS: VQT proofs the concept that qualitative results from real-time RT-PCR assays can be converted into quantitative determination of virus load in clinical samples without running standard curves in parallel.
BACKGROUND: The pan-influenza A real-time RT-PCR detection assay developed by the Centers for Disease Control and Prevention (CDC) during the 2009 pandemic is widely utilized. A quantitative version of the assay may be useful to monitor influenza A infection and response to treatment. OBJECTIVES: To prove in principle the possibility that a virtual quantification tool (VQT) would allow conversion of CDC real-time RT-PCR cycle threshold (Ct) values in virus RNA copy number. STUDY DESIGN: A plasmid carrying the CDC real-time RT-PCR target region of the influenza A Matrix (M) gene was generated. In a multicenter study, a set of 5 ten-fold dilutions (equivalent to 1×10(2) to 1×10(6)copies/reaction) were prepared and distributed to the 4 participating virology laboratories and then amplified to generate a virtual quantification standard curve. Clinical samples (n=120) were quantified in parallel by interpolation with locally generated standard curves and using the VQT. RESULTS: A total of 40 standard curves were obtained by the participating centers (ten from each center). The intra- and inter-laboratory variability showed a coefficient of variation (CV) ≤5%. Influenza A virus quantification in 120 respiratory samples showed a significant correlation between interpolation with locally generated standard curves and the VQT (R(2)=0.9655). Bland Altman analysis showed that the majority (no. 111, 92.5%) of clinical samples had <0.5 log(10) variation. CONCLUSIONS: VQT proofs the concept that qualitative results from real-time RT-PCR assays can be converted into quantitative determination of virus load in clinical samples without running standard curves in parallel.
Authors: Jernej Pavšič; Alison S Devonshire; Helen Parkes; Heinz Schimmel; Carole A Foy; Maria Karczmarczyk; Ion Gutiérrez-Aguirre; Isobella Honeyborne; Jim F Huggett; Timothy D McHugh; Mojca Milavec; Heinz Zeichhardt; Jana Žel Journal: J Clin Microbiol Date: 2014-11-12 Impact factor: 5.948
Authors: Jianling Xie; Xiao-Li Pang; Gillian A M Tarr; Yuan Mu; Ran Zhuo; Linda Chui; Bonita E Lee; Otto G Vanderkooi; Phillip I Tarr; Samina Ali; Shannon E MacDonald; Stephen B Freedman Journal: J Clin Virol Date: 2020-08-01 Impact factor: 3.168
Authors: Cheryl L Sargel; Mohammed Aboud; Aimee Forster; Loralie J Langman; Jessica Tansmore; Bruce A Mueller; William E Smoyer; Jeffery J Auletta Journal: J Pediatr Pharmacol Ther Date: 2018 Jul-Aug
Authors: Mark G Thompson; Jeannette R Ferber; Roxana Odouli; Donna David; Pat Shifflett; Jennifer K Meece; Allison L Naleway; Sam Bozeman; Sarah M Spencer; Alicia M Fry; De-Kun Li Journal: Influenza Other Respir Viruses Date: 2015-05 Impact factor: 4.380
Authors: Jeannette M Watson; James N Francis; Sofie Mesens; Gabriel A Faiman; Jill Makin; Peter Patriarca; John J Treanor; Bertrand Georges; Campbell J Bunce Journal: Virol J Date: 2015-02-03 Impact factor: 4.099
Authors: Alimuddin Zumla; Jaffar A Al-Tawfiq; Virve I Enne; Mike Kidd; Christian Drosten; Judy Breuer; Marcel A Muller; David Hui; Markus Maeurer; Matthew Bates; Peter Mwaba; Rafaat Al-Hakeem; Gregory Gray; Philippe Gautret; Abdullah A Al-Rabeeah; Ziad A Memish; Vanya Gant Journal: Lancet Infect Dis Date: 2014-09-01 Impact factor: 25.071
Authors: Victoria M W Gould; James N Francis; Katie J Anderson; Bertrand Georges; Alethea V Cope; John S Tregoning Journal: Front Microbiol Date: 2017-05-17 Impact factor: 5.640